A recent Philadelphia Inquirer article examined the new guidelines for the prevention of cardiovascular disease from the American Heart Association and the American College of Cardiology. They looks closely at cholesterol control and expands the use of cholesterol-lowering statin medications.
The article notes that Jefferson cardiologist David L. Fischman, MD, questioned whether it made sense to give diabetics with low levels of “bad” LDL the drugs, while not recommending them for those people with a family history of cardiovascular disease.
In general, however, Dr. Fischman says that patients can adjust to the new goals for cholesterol control established by the guidelines with their physicians help in explaining the goals and how to meet them.
Click here to read the full article.